Stocksigma LogoStocksigma Logo

Orchid Pharma Signs $80M Latin America Licensing Deal for Exblifep

Orchid Pharma Ltd. entered a licensing and supply agreement on 24th Oct'26 with Laboratorio Libra S.A

Orchid Pharma Signs $80M Latin America Licensing Deal for Exblifep

Orchid Pharma Ltd 路 Press Release 路 24 Oct 2026, 10:33 pm

Orchid Pharma Signs $80M Latin America Licensing Deal for Exblifep Orchid Pharma Ltd. entered a licensing and supply agreement on 24th Oct'26 with Laboratorio Libra S.A. to expand its novel antibiotic Exblifep across nine Latin American markets, including Chile, Costa Rica, Ecuador, and Uruguay. Orchid will manufacture and supply finished dosage forms, while Libra holds exclusive registration, import, and marketing rights. The 10-year partnership presents an estimated $80 million commercial opportunity based on projected regional demand. Commercial rollouts remain subject to local regulatory approvals.

Original exchange filing (PDF)

More announcements from Orchid Pharma Ltd

All Orchid Pharma Ltd announcements